ImageneBio (IMA) Cash from Financing Activities (2020 - 2023)
Historic Cash from Financing Activities for ImageneBio (IMA) over the last 4 years, with Q4 2023 value amounting to $60000.0.
- ImageneBio's Cash from Financing Activities rose 590000.0% to $60000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $39.0 million, marking a year-over-year increase of 346191.78%. This contributed to the annual value of $76.0 million for FY2023, which is 683881.28% up from last year.
- As of Q4 2023, ImageneBio's Cash from Financing Activities stood at $60000.0, which was up 590000.0% from $38.9 million recorded in Q3 2023.
- Over the past 5 years, ImageneBio's Cash from Financing Activities peaked at $132.5 million during Q1 2021, and registered a low of -$1.1 million during Q2 2021.
- Its 4-year average for Cash from Financing Activities is $24.0 million, with a median of $152500.0 in 2021.
- Examining YoY changes over the last 5 years, ImageneBio's Cash from Financing Activities showed a top increase of 63098571.43% in 2021 and a maximum decrease of 9979.68% in 2021.
- ImageneBio's Cash from Financing Activities (Quarter) stood at $116.2 million in 2020, then crashed by 99.8% to $236000.0 in 2021, then plummeted by 99.58% to $1000.0 in 2022, then skyrocketed by 5900.0% to $60000.0 in 2023.
- Its Cash from Financing Activities was $60000.0 in Q4 2023, compared to $38.9 million in Q3 2023 and $1000.0 in Q4 2022.